Logos Global Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-500,000
| Closed | -$11.3M | – | 50 |
|
2024
Q3 | $11.3M | Buy |
+500,000
| New | +$11.3M | 1.22% | 27 |
|
2023
Q3 | – | Sell |
-520,000
| Closed | -$13.3M | – | 55 |
|
2023
Q2 | $13.3M | Sell |
520,000
-230,000
| -31% | -$5.87M | 1.81% | 19 |
|
2023
Q1 | $16M | Sell |
750,000
-685,000
| -48% | -$14.6M | 2.28% | 17 |
|
2022
Q4 | $42.5M | Sell |
1,435,000
-565,000
| -28% | -$16.7M | 4.98% | 6 |
|
2022
Q3 | $46.5M | Buy |
2,000,000
+300,000
| +18% | +$6.98M | 5.72% | 6 |
|
2022
Q2 | $28.5M | Buy |
1,700,000
+750,000
| +79% | +$12.6M | 5.23% | 7 |
|
2022
Q1 | $41.7M | Buy |
950,000
+80,000
| +9% | +$3.51M | 5.4% | 8 |
|
2021
Q4 | $53M | Sell |
870,000
-605,000
| -41% | -$36.8M | 5.46% | 4 |
|
2021
Q3 | $61.3M | Buy |
1,475,000
+760,000
| +106% | +$31.6M | 4.42% | 4 |
|
2021
Q2 | $21.7M | Sell |
715,000
-85,000
| -11% | -$2.58M | 1.82% | 20 |
|
2021
Q1 | $23.9M | Buy |
+800,000
| New | +$23.9M | 2.33% | 12 |
|